Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Viking Holdings Ltd. is banking on affluent customers to see it through this period of jitters in the travel industry.While ...

Goldman Sachs analyst Lizzie Dove reiterated a Neutral rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...

Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern. The ...

Viking Cruises' unique ship designs, being small and almost identical, set the company apart and serve as an important value ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

VIKING NEBULA shows what happens when military operation planners try to come up with a good mission name, unlike Odyssey Dawn.

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...

Viking Holdings told investors Tuesday during its Q4 earnings call that the company has sold 88% of 2025 inventory, with ...

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...